Trial Details
COMPLETEDBasic Information
| Clinical ID | c3042 |
|---|---|
| Identifier | NCT02611817 |
| Trial Title | Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Vedolizumab SC 108 mg|DRUG: Placebo|DRUG: Vedolizumab IV 300 mg |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | Phoenix |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2016-01-04 |
|---|---|
| Primary Completion Date | 2019-05-06 |
| Completion Date | 2019-08-06 |